Over 600 Reproductive Endocrinologists (Fertility Specialists) routinely use ReceptivaDx testing in the US for the patients with failed IVF, unexplained infertility and/or recurrent pregnancy loss.
Here are what some of our providers have to say about ReceptivaDx:
MD – CCRM San Francisco Menlo Park, CA
“ReceptivaDx provides unique information for our patients with unexplained infertility, failed IVF history and those with recurrent pregnancy loss. In the past, so many of these patients would simply give up. The test has made a significant difference in our practice. “
“I was one of the early adopters of the ReceptivaDx test. Our experience has exceeded my expectations. We can now identify and treat women with early endometriosis who might have gone undetected before. For our patients, this has led to improved success rates, reduced costs and the avoidance of multiple IVF cycles. “
M.D. – MCRM Fertility Chesterfield, Missouri
“ReceptivaDx has given me insight into previously unexplained infertility and failed IVF along with treatment options for my patients. “
M.D. Physician – Central Coast Fertility San Luis Obispo, CA
“Endometriosis/uterine receptivity defects are common and in this ‘no laparoscopy’ era, ReceptivaDx is essential for diagnosis and treatment planning.”
The ReceptivaDxTM Test was developed by Cicero Diagnostics in conjunction with Pathology Consultants, Inc. of Greenville, SC. Pathology Consultants, Inc. is a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). As with other laboratory-developed tests, this testing service has not been cleared or approved by the US FDA or any other federal regulatory agencies. Data have not been submitted to or evaluated by Federal regulatory agencies and the test is not for sale as an In Vitro Diagnostic (IVD) in the US or the EU.
Copyright © 2023 ReceptivaDx™ | All Rights Reserved